𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics

✍ Scribed by Bertrand Tombal; Kurt Miller; Laurent Boccon-Gibod; Fritz Schröder; Neal Shore; E. David Crawford; Judd Moul; Jens-Kristian Jensen; Tine Kold Olesen; Bo-Eric Persson


Book ID
113611706
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
350 KB
Volume
57
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.